Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
662.00    -3.00 (-0.45%)
Bid:
662.00
Ask:
663.00
Spread: 1.00 (0.151%)
Market Cap: £538.84m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Holding(s) in Company

23 Oct 2009 12:25

RNS Number : 2987B
Bloomsbury Publishing PLC
23 October 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Bloomsbury Publishing plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 Capital Group International, Inc.

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 21 October 2009

6. Date on which issuer notified:

 22 October 2009

7. Threshold(s) that is/are crossed or reached:

 Below 6%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Indirect

Direct

Indirect

Direct

Indirect

 Ordinary Shares

 6,235,385

 6,235,385

 4,506,185

 

 4,506,185

 

 6.1156%

 GB0033147751

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 n/a

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 n/a

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 4,506,185

 6.1156%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 

15. Contact telephone number:

 

As of 21 October 2009

 

Bloomsbury Publishing plc

 

Number of Shares

Percent of Outstanding
Capital Group International , Inc. ("CGII") holdings 4,506,185 6.116%
Holdings by CGII Management Companies and Funds:
Capital Guardian Trust Company Capital Guardian International (Non-U.S.) Small Capitalization Master Fund 4,053,185 5.501%
Capital International Limited 453,000 0.615%
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOORRKWRRUAA
Date   Source Headline
8th Jun 20263:20 pmRNSHolding(s) in Company
22nd May 20268:38 amRNSHolding(s) in Company
20th May 20267:00 amRNSAppointment of Non-Executive Director
20th May 20267:00 amRNSAudited Preliminary Results
12th May 20267:00 amRNSNotice of Preliminary Results
30th Apr 20262:47 pmRNSHolding(s) in Company
23rd Apr 202612:25 pmRNSHolding(s) in Company
15th Apr 202612:49 pmRNSAppointment of Executive Director - Replacement
15th Apr 20267:00 amRNSAppointment of Executive Director
1st Apr 20269:00 amRNSHolding(s) in Company
24th Mar 20267:22 amRNSHolding(s) in Company
19th Mar 20261:15 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
18th Feb 20265:51 pmRNSHolding(s) in Company
13th Feb 202610:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Feb 20264:39 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNS-RBloomsbury to grow Academic sales in Asia
8th Dec 202510:05 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSGoogle and Bloomsbury Strategic Collaboration
19th Nov 202511:53 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSUnaudited Interim Results
8th Oct 20257:00 amRNS-RAuthor Katherine Rundell announces multi-film deal
2nd Oct 20255:22 pmRNSHolding(s) in Company
22nd Sep 20254:20 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSAppointment of Chief Financial & Operating Officer
29th Aug 20253:39 pmRNSDirector/PDMR Shareholding
28th Aug 20254:16 pmRNSDirector/PDMR Shareholding
28th Aug 20253:51 pmRNSDirector/PDMR Shareholding
15th Aug 20259:34 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 202512:11 pmRNSDirector/PDMR Shareholdings - Correction
12th Aug 20254:29 pmRNSDirector/PDMR Shareholding
11th Aug 202511:08 amRNSDirector/PDMR Shareholding
5th Aug 202511:31 amRNSHolding(s) in Company
1st Aug 20251:14 pmRNSDirector/PDMR Shareholding
31st Jul 202511:10 amRNSDirector/PDMR Shareholding
30th Jul 20253:55 pmRNSHolding(s) in Company
29th Jul 20253:08 pmRNSHolding(s) in Company
28th Jul 20254:39 pmRNSHolding(s) in Company
25th Jul 20253:13 pmRNSHolding(s) in Company
24th Jul 20253:48 pmRNSHolding(s) in Company
17th Jul 20253:46 pmRNSHolding(s) in Company
16th Jul 20253:16 pmRNSResults of the 2025 Annual General Meeting
16th Jul 20257:00 amRNSAGM Trading Update
15th Jul 20254:14 pmRNSHolding(s) in Company
4th Jul 20253:54 pmRNSHolding(s) in Company
2nd Jul 20254:39 pmRNSHolding(s) in Company
13th Jun 20255:33 pmRNSAnnual Financial Report
22nd May 20257:00 amRNSAnnual Financial Report
15th May 20257:00 amRNSNotice of Preliminary Results
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.